fda ruling on semaglutide Compounded Manufacturing Ban FDA Clears Semaglutide For Cardiac

The labels are entering stores without us knowing whether theyll be helpful and accurately understood or could cause confusion, said Eva Greenthal, a senior policy scientist who studies federal food labeling at the Center for Science in the Public Interest

Studies show many patients regain about two-thirds of the weight they lost within a year of stopping semaglutide

Clinical studies provide evidence that these agonists can lower alcohol consumption in humans, especially in overweight individuals with AUD

Knasmuller S., Parzefall W., Helma C., Kassie F., Ecker S., Schulte-Hermann R

In recent months, multiple reports have surfaced of patients suffering life-threatening complications after using unapproved compounded GLP-1 medications

J Am Coll Cardiol 2023;81:1902-14.ArticlePubMed 113